Juan Manuel Tiraboschi (Juan Tiraboschi, J Tiraboschi, Juan M Tiraboschi, J M Tiraboschi)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Hiv Infected Patients

Gas Chromatography Mass Spectrometry

Men Who Have Sex With Men

Top Venues

The Journal of antimicrobial chemotherapy

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

The Journal of infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Felix Gutiérrez, Leandro López, Carlos Galera, Juan Manuel Tiraboschi, Joseba Portu, Lucio J García-Fraile, Miguel García Del Toro, Enrique Bernal-Morell, Antonio Rivero, Javier García-Abellán, Juan Flores, Ana González-Cordón, Onofre Martínez, Joaquín Bravo Urbieta, Dácil Rosado, Marta Montero-Alonso, Guillem Sirera, Miguel Torralba González de Suso, Maria José Galindo, Juan Macías, Inmaculada Gónzalez, Vicente Boix, María Jesús Vivancos, Paula Dios, José-Ramon Blanco, Sergio Padilla, Marta Fernández-González, Ana Gutiérrez, Esteban Martínez, Mar Masiá, null null
Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy (2024)
Elisa de Lazzari, Eugenia B Negredo, Pere Domingo, Juan Manuel Tiraboschi, Esteve Ribera, Nadia Abdulghani, Verònica Alba, Salvador Fernández-Arroyo, Consuelo Viladés, Joaquim Peraire, Jose M Gatell, Jose L Blanco, Francesc Vidal, Anna Rull, Esteban Martinez
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Inés Suárez-García, Belén Alejos, Victoria Hernando, Laura Viñuela, Mar Vera García, David Rial-Crestelo, María Jesús Pérez Elías, Helena Albendín Iglesias, Joaquim Peraire, Juan Manuel Tiraboschi, Asunción Díaz, Santiago Moreno, Inma Jarrín, null null
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice. The Journal of antimicrobial chemotherapy (2023)
Juan Manuel Tiraboschi, Jhon Rojas, Henrik Zetterberg, Kaj Blennow, Jordi Niubo, Johanna M Gostner, Antonio Navarro-Alcaraz, Camila Piatti, Dietmar Fuchs, Magnus Gisslén, Raul Rigo-Bonnin, Esteban Martinez, Daniel Podzamczer
No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62). The Journal of infectious diseases 223 (11) (2022)
Maria Saumoy, S Di Yacovo, S Pérez, J L Sánchez-Quesada, J M Valdivielso, I Subirana, A Imaz, Juan Manuel Tiraboschi, B García, J Ordoñez-LLanos, S Benítez, D Podzamczer, M Grau
Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations. HIV medicine 22 (7) (2021)
Josep Maria Llibre, A Montoliu, J M Miró, P Domingo, M Riera, Juan Manuel Tiraboschi, A Curran, F Homar, J Ambrosioni, N Abdulghani, L Force, J Peraire, J Casabona, null null
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort. HIV medicine 20 (3) (2019)